EGFR and hepatocellular carcinoma: In addition, several studies have demonstrated that EGF/EGFR overexpression results in aggressive HCC and metastasis by activating AKT/ERK signaling to regulate MMP2, disrupting desmosomes and adherens junctions, as well as decreasing E-cadherin, encoded by CDH1 [22,23].